Patent details
LUC00207 Product Name: A combination of (a) (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide or a pharmaceutically acceptable salt thereof and (b) N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide or a pharmaceutically acceptable salt thereof
Basic Information
- Publication number:
- LUC00207
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP141729913
- Legal Status:
- Inactive
- Application number:
- LUC00207
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/18/1306
- Marketing Authorization Type:
- Marketing Authorization Date:
- 06/11/2018
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 18/05/2021
- First Marketing Authorization date:
- 06/11/2018
- Grant date:
- 04/10/2024
- Activation date:
- Publication date:
- 18/05/2021
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 06/11/2033
- SPC Extension Expiration:
- 06/11/2033
- Rejection date:
- Withdrawal date:
Owner
- From:
- 18/05/2021
- Name:
- Vertex Pharmaceuticals Incorporated
- Address:
- 50 Northern Avenue, Boston, MA 02210, United States (US)
Agent
- Name:
- Dennemeyer & Associates S.A.
- From:
- 18/05/2021
- Address:
- 55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2021/07
- Publication date:
- 03/06/2021
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2024/13
- Publication date:
- 05/11/2024
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 31/03/2031
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 18/05/2021 | General Document | 1 |
| 18/05/2021 | Outgoing Correspondence | 1 |
| 18/05/2021 | MA publication | 6 |
| 18/05/2021 | General Document | 68 |
| 18/05/2021 | Application Form | 5 |
| 18/05/2021 | Marketing authorization | 4 |
| 18/05/2021 | Summary of the product caracteristics | 19 |
| 18/05/2021 | Publication | 1 |
| 04/10/2024 | Publication | 1 |
| 04/10/2024 | Certificate | 1 |
| 04/10/2024 | Outgoing Correspondence | 1 |